Connect with us

American Cannabis News

Tilray Is a Dangerous Stock – New Cannabis Ventures

Published

on

Tilray Is a Dangerous Stock – New Cannabis Ventures

You read this week’s publication New Cannabis Ventures Weekly Newsletter we publish from October 2015. We no longer send them. By mail as before but we post this and all newsletters On our website hereA number

Friends,

In April I suggested Sale of MSOS ETF to buy Canadian LPsI even went to Tilray brands at that time. Of course, MSOS has grown when earning one ton since then.

I don’t always get the right things because I can’t make the future perfect. For me, the good news was that MSOs had grown, so there have been other Canadian LPs since then, including two I have called here by 255% per day.

Until Tlry is still down 2025 I don’t like it, even though I think it needs to be better than MSOS. It has been a very unstable stock. I don’t like it for a long time and started it very soon. I went with it with it and after a big rally, I went down to keep it from a strong price last week, and I have reduced it earlier to sell alpha. The stock deal is premium for the value of a tangible book and it seems expensive for me compared to other cannabis shares and one alcoholic fund, which I carefully follow. Yes, it can come forward, but it has gone on the wrong reason, as this company has no effect on the USA target in the USA, which is significantly lower than the current price.

I continue to have an impact on my model portfolio. The effect of the model portfolio is still low compared to the global impact of Cannabis Stock Index, which is currently 37.5%. I now have a lot of money (allowed maximum), and I am overweight, where I currently hold three names, including 2 cannabis. I explained Why do I like Cannabis Reits Last week.

I continue to be very careful in Cannabis shares. Many traders believe that 280E taxation will disappear that can. I hope it does. If this is not the case, I think it will be destructive to MSOS. By the way, MSOS has been withdrawn from where he was 9% a week ago. The two ruts I mentioned have been dropped long in my model portfolio. Again, I think they could go down if 280e doesn’t leave, but they are less risky than most MSOS.

Thus, Cannabis shares that are slightly annually, as measured by the NCV Global Cannabis stock index. Investors must be careful here. MSOS is not a way to invest in the field, nor is the TILRAY brands in my view. Good luck to all in this volatile market.

Frankly,

Alan


New hemp enterprises publish medicine articles, as well as exclusive news. Here is what we published this last week.

Exclusive

The sales of weak Michigan Cannabis again in July

Mergers and achievements

German retail achievement expected for high wave

To get real-time updates as our Facebook page or follow Alan RationSharing a number and discover industry news along with supporters, the largest hemp group and entrepreneurs group ConnectionA number

Watch Revenue and Revenue Search Engine:which occupies the best income producing Cannabis shares.

Stay on top of some important communications of public companies by watching upcoming Cannabis Investor Calendar:A number

Alan-Browntyin, CFA

Based on the Houston, Alan cries out his experience as the founder of the online community 420 InvestorThe first and still the biggest decent diligent platform focused on the shares sold in the cannabis industry. Alan continues to find new ways to connect industry and facilitate its sustainable growth in the Canepuni community. Approximately New hemp enterprisesHe is responsible for content development and strategic alliances. Until the early 2013 focuses on the cannabis industry, Alan, who began his career in Wall Street, worked as more than two decades of research and portfolio. Article 650 of the Article 650 published in 2007 Looking for alphaWhere he has 70,000 followers, Alan is a frequent speaker for industry conferences and a Frequent source The media, including NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Ration | Facebook | Connection | Email

Get our Sunday newsletter





American Cannabis News

Curaleaf Q2 Revenue Falls 8% – New Cannabis Ventures

Published

on

By

Curaleaf Q2 Revenue Falls 8% – New Cannabis Ventures

Curaleaf reports 2025 results of the second quarter. Internal stabilization, strong international momentum
  • The second quarter 2025 total income of $ 315 million
  • The second quarter of 2025 international income, $ 41 million
  • The second quarter 2025 adjusted gross margin 49%
  • He was awarded at the NASCENT MESTIONAL MESTIONAL MESTIONAL MESTIONAL MESTIONAL MESTIONAL MESTIONAL MESTIONAL MESTIONAL MESTIONAL MESTIONAL MESTIONAL MESTIONAL MESTIONAL MESTIONAL MESTIONAL MESTIONAL MESTIONAL MESTIONAL MESTIONAL MESTIONAL MESTIONAL MESTIONAL MESTIONAL MESTIONAL MESTIONAL MESTIONAL MESTION

Stamford, Conn., 6, 2025 / PRNEWSWIRE / – Curaleaf Holdings, Inc. (TSX: Cura) (otcqx: Curaleaf or Curaleaf, the leading international supplier of consumer goods at Cannabis, reports that it is planned for the last second quarter, unless otherwise stated.

Kuralef President and Chief Executive Director Boris Jordan, the income of the second quarter, compared to the first quarter, was 66 million dollars for the previous quarter. Growth We ended Q2 with $ 102 million in cash, $ 47 million, and debt payment. “

Mr. Jordan continued. The growth. Through the collection of assets built and the asset database, we are now tightening our attention to the quality of the quality of the product, customer service and chain of excellence.

Second quarter 2025 Financial importance

  • A net income worth $ 314.5 million, a year annually, is 8% compared to 342.3 million dollars in the quarter of 8224. Sequential, net income increased by 1.5% compared to 310.0 million US dollars in 2025
  • Gross profit: $ 152.6 million and gross margin, 49%, 160 basic points per year
  • Adjusted gross profit of $ 153.5 million and adjusted gross margin (1) 49%, 120 base scores increase
  • Net loss attributed to Curaleaf Holdings, Inc. $ 50.6 million or net loss from one share of $ 0.07 on continuous activities
  • Adjusted net losses from $ 47.8 million to one share of $ 0.06 per share
  • Adjusted eBitda¹ is $ 65.5 million
  • At the end of the quarter was $ 102.3 million

Original press release

Published by NCV NewsWire

NCV NewsWire:

NCV NewsWire aims to treat high-quality content and information about cannabis companies by New Cannabis Ventures to help our readers make noise and remain the most important cannabical business news. NCV Newswire is hand treated by hand and is not automated. Have secret news tip. Contact:A number

Get our Sunday newsletter





Continue Reading

American Cannabis News

The 3 Big MSOs Report Q2 – New Cannabis Ventures

Published

on

By

The 3 Big MSOs Report Q2 – New Cannabis Ventures

You read this week’s publication New Cannabis Ventures Weekly Newsletter we publish from October 2015. We no longer send them. By mail as before but we post this and all newsletters On our website hereA number

Friends,

Yesterday for MSOS, the Q2 earning season has started for MSOS, and the three largest MSOS updates through press release and conference calls. Recently shared this site Report prospects::

Scenes were gloomy. The archery in the market opening on Wednesday, and the income and adjusted EBITDA was higher, but not very interesting. The Q3 guide was soft. The company completed Q2 with net debt for only $ 85.3 million, but it does not contain $ 746 million in tax liabilities. The GTI and Curalef and Curalef had the same time (GTI announced its time on July 2, and Curaleaf was scheduled for the same time). GTBIF has had a weak quarter, a decline in margins. The company suspends its quarterly conference, which is upcoming. Curaleaf was a weak quarter, but it hit the scores.

In 2025, Curalef is now a price at the beginning of this year. Here are the three-year-old return of these three companies.

  • Curaleaf. + 99.2% in Q3 so far and up to 7.7%
  • Green dull industry. + 24.7% in Q3 so far, but down by 15.9% per year
  • Walk. + 39.0% in Q3 so far and lift 1.9% per year

MSOS increased by 37.8% in Q3, but so far it has dropped 12.9% in 2025, closing for $ 3.30. It has a lot of positions in these three MSOS, which currently make up 69.4% of the portfolio. The NCV Global Cannabis stock index decreased by 19.5% so far in 2025 and has been raised by 10.4% so far.

MSOS has recently seen the growth of its shares after decreasing in the spring and has a stock count, which is now 150,275 million to 15.1%. In 2025, it strengthened its property in two large 3 MSOS.

  • GTI: -7.0%
  • Walk, + 11.2%
  • Curraleaf: + 20.7%

I continue to be very careful on MSOS and think that investors should get out of MSOS and each of these three MSOS. There are better ways to invest in Canada.

Frankly,

Alan


New hemp enterprises publish medicine articles, as well as exclusive news. Here is what we published this last week.

Exclusive

The hemp sales were soft in July

In July, snow stocks increased

Financial statements

Curaleaf Q2 income falls 8%

Green Thumb Industries Q2 income increases by 5%

Q2 Q2 Earnings

Mergers and achievements

IIPR spreads beyond hemp

To get real-time updates as our Facebook page or follow Alan RationSharing a number and discover industry news along with supporters, the largest hemp group and entrepreneurs group ConnectionA number

Watch Revenue and Revenue Search Engine:which occupies the best income producing Cannabis shares.

Stay on top of some important communications of public companies by watching upcoming Cannabis Investor Calendar:A number

Alan-Browntyin, CFA

Based on the Houston, Alan cries out his experience as the founder of the online community 420 InvestorThe first and still the biggest decent diligent platform focused on the shares sold in the cannabis industry. Alan continues to find new ways to connect industry and facilitate its sustainable growth in the Canepuni community. Approximately New hemp enterprisesHe is responsible for content development and strategic alliances. Until the early 2013 focuses on the cannabis industry, Alan, who began his career in Wall Street, worked as more than two decades of research and portfolio. Article 650 of the Article 650 published in 2007 Looking for alphaWhere he has 70,000 followers, Alan is a frequent speaker for industry conferences and a Frequent source The media, including NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Ration | Facebook | Connection | Email

Get our Sunday newsletter





Continue Reading

American Cannabis News

Cresco Labs Reports 11% Q2 Revenue Decline – New Cannabis Ventures

Published

on

By

Cresco Labs Reports 11% Q2 Revenue Decline – New Cannabis Ventures

CRESCO LABS SOLID Q2 PAINTING AND DEPARTMENT Refinancing The basis for the creation of long-term value

Chicago- (Business Wire) – CRESCO LABS INC. (CL) (OTCQX: CRLBF) (FSE: USD, unless otherwise stated and available on the company’s investors’ website, here.

The second quarter 2025 important events

  • The income of the second quarter of $ 164 million. The second quarter, which operates cash flow, $ 9 million.
  • Gross profit: $ 83 million. Adjusted gross profit – $ 83 million; and adjusted gross margin in the amount of 50.6% of income.
  • SG & A $ 51 million or 31.4% of income.
  • The net loss of $ 14 million includes an unresolved charging of $ 9 million in California’s assets.
  • The second quarter adjusted Ebitda¹ to $ 41 million and adjusted Ebitda margin, 25.0%.
  • Maintained the position of shares # 1 in many billion dollars markets.

Management Comment:

In Q2, we showed strongly in accordance with the guidance, preserved the share of our market in a high competitive environment and continued to make cash with our balance and maintains our balance sheet. Near time priorities and long-term growth opportunities. “

“The hemp industry enters a new phase, which is defined by consolidation and intelligence. choice partner as a consolidation of industry. “

Balance, liquidity and other financial information

  • As of June 30, 2025, current assets amounted to $ 315 million, including cash and cash equivalents, $ 147 million. The company had a senior secured credit loan debt, discount and release costs, $ 354 million and mortgage loans, discount net and release costs.
  • The shares of voting on a fully converted basis were 483.444.948, as of June 30, 2025.

“Non-GAAP FINANCIAL” “NON GAAP FINANCIAL”, the company’s non-GAP financial measures for the use of financial events.

²Achding to Hoodie Analytics.

Conference call and web wash

The company will host a conference call and web web, on Thursday, August 7, 2025, Eastern time. 30 o’clock at 8 o’clock. On 30. The conference call can access WEBCAST or 1-433-470-1428 or 1-404-975-4839 (Local) provides 158138 access code.

CRESCO LABS INC.

CRESCO LABS mission is to normalize the cannabis industry and professionalize the construction of national brands and the construction of a customer-based retail experience, while a business economy for existing legislative and regulatory initiatives. As a leader of cultivation, production and brand distribution, the company uses its scale and agility to grow its brands portfolio, which includes CRESCO, High Supply, Floracal, Good news, Mindy’s and Remedi, Mindy’s and Remedi. The company also operates very effective dispenses, which are located under the Sunnyside brand, which focus on the construction of the patient’s and consumer confidence during continuous education and convenience. Efforts to the Community Area and Seed Initiative throughout the Policy, CRESCO Labs presents the responsibility of supporting communities through valid involvement, economic opportunities, investments, labor, and legislative initiatives, which have been developed as possible. Learn more about Cresco Labs travel by visiting www.crescolabs.com or Following the company on Facebook, X or LinkedIn.

Original press release

Published by NCV NewsWire

NCV NewsWire:

NCV NewsWire aims to treat high-quality content and information about cannabis companies by New Cannabis Ventures to help our readers make noise and remain the most important cannabical business news. NCV Newswire is hand treated by hand and is not automated. Have secret news tip. Contact:A number

Get our Sunday newsletter





Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media